HLA-B-ASTERISK-5101 IN GREEK PATIENTS WITH BEHCETS-DISEASE

Citation
Y. Koumantaki et al., HLA-B-ASTERISK-5101 IN GREEK PATIENTS WITH BEHCETS-DISEASE, Human immunology, 59(4), 1998, pp. 250-255
Citations number
32
Categorie Soggetti
Immunology
Journal title
ISSN journal
01988859
Volume
59
Issue
4
Year of publication
1998
Pages
250 - 255
Database
ISI
SICI code
0198-8859(1998)59:4<250:HIGPWB>2.0.ZU;2-A
Abstract
Behcet's disease (BD) is a recurrent systemic vasculitis of unknown et iology. Genetic factors and infectious agents seem to be related ro th e etiology and pathogenesis of the disease. ED is strongly associated with HLA-B51 antigen in many ethnic groups. As there are differences i n HLA profile in different ethnic groups, we designed this case-contro l study to examine the association of HLA-B51 alleles and ED as well a s to investigate the influence of sex, age at development of the Inter national Study Group (ISG) for Behcet's Disease criteria and certain f eatures of disease severity on the strength of this association.The st udy includes 62 Greek ED patients who fulfil the ISG criteria for Behc et's disease and 87 controls. Serological HLA Class-I typing was perfo rmed by standard microlymphocytotoxicity technique. HLA-DNA typing for the B5 group was performed in all B51 subjects and controls by PCR-SS O. Allele B5101 was found in 80% of ED patients and in 26% of control s (odds ratio (OR) 10.48, p < 10(-6)). Males who carry this allele hav e a higher risk than females for ED (OR 16.97 and 5.74 respectively). B5101 predisposes to ED at a younger age in both sexes and to the dev elopment of erythema nodosum (OR = Il, P = 0.004). This was confirmed by multiple logistic regression analysis. A weak but not significant a ssociation was found between B5101 and uveitis (OR = 2). No associati on was found between B5101 and vasculitis or skin lesions in either s ex. It was concluded that in the Greek population allele B5101 is a p redisposing marker for ED, as in most ethnic groups, and that this all ele predisposes to the development of the disease at a younger age in both sexes and to the development of erythema nodosum. (C) American So ciety for Histocompatibility and Immunogenetics, 1998. Published by El sevier Science Inc.